- Paul Napoli | March 01, 2012 3:33 PM | New York City, NY
Category:
FDA & Prescription Drugs
Federal regulators are updating the safety labeling of cholesterol fighting statins, some of the most widely used medications in the United States.
The U.S. Food and Drug Administration (FDA)...
- Paul Napoli | December 26, 2010 9:34 PM | New York City, NY
Category:
Medical Devices & Implants
December 26, 2010
Abbott Diabetes Care, a division of Abbott Laboratories, is voluntarily recalling 359 million test strips used by diabetics to monitor blood glucose levels.
According to the U.S...
- Paul Napoli | June 10, 2011 11:41 PM | New York City, NY
Category:
FDA & Prescription Drugs
June 10, 2011
Regulators in France and Germany yesterday pulled Actos (pioglitazone), the most widely used medication for the treatment of type 2 diabetes, off the market after a study sponsored by...
- Paul Napoli | May 19, 2010 1:05 AM | New York City, NY
Category:
Miscellaneous
A new study has found that eating processed meats such as hot dogs, sausage, bacon and deli meat may dramatically increase risk of developing heart disease and diabetes.
Study researchers from the...
- Paul Napoli | March 08, 2011 10:54 PM | New York City, NY
Category:
Medical Devices & Implants
March 8, 2011
Leaking Insulin Pump Cartridges are under recall because the leak may interfere with its performance and create potentially life-threatening conditions.
Two reports of leaking...
- Paul Napoli | May 18, 2010 12:54 AM | New York City, NY
Category:
Medical Malpractice
Errors by medical students hosting a Diabetes Testing event at the Indian Pueblo Cultural Center in Albuquerque on April 24, 2010, may have exposed participants to certain diseases, including...
- Paul Napoli | September 23, 2010 11:48 PM | New York City, NY
Category:
FDA & Prescription Drugs
September 23, 2010
The U.S. Food and Drug Administration (FDA) announced today that the agency is significantly restricting the use of the diabetes drug Avandia (rosiglitazone) due to data that...
- Paul Napoli | September 18, 2010 12:19 AM | New York City, NY
Category:
FDA & Prescription Drugs
September 17, 2010
The U.S. Food and Drug Administration (FDA) announced today that the agency is reviewing data from an ongoing 10-year study to evaluate whether Actos (pioglitazone) is associated...